Prednisolone does not affect direct‐acting antivirals against hepatitis C, but inhibits interferon‐alpha production by plasmacytoid dendritic cells

Publisher： John Wiley & Sons Inc

E-ISSN： 1399-3062|1398-2273|5|707-715

ISSN： 1398-2273

Source： TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol.1398-2273, Iss.5, 2015-10, pp. : 707-715

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prednisolone does not affect direct‐acting antivirals against hepatitis C, but inhibits interferon‐alpha production by plasmacytoid dendritic cells

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 17, Iss. 5, 2015-10 ,pp. : 707-715

John Wiley & Sons Inc

Access to resources Recommend Favorite

Interferon‐free therapy of chronic hepatitis C with direct‐acting antivirals does not change the short‐term risk for de novo hepatocellular carcinoma in patients with liver cirrhosis

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 4, 2018-02 ,pp. : 516-525

John Wiley & Sons Inc

Access to resources Recommend Favorite

Minimum target prices for production of direct‐acting antivirals and associated diagnostics to combat hepatitis C virus

By  

HEPATOLOGY, Vol. 61, Iss. 4, 2015-04 ,pp. : 1174-1182

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sofosbuvir plus pegylated interferon and ribavirin in patients with genotype 1 hepatitis C virus in whom previous therapy with direct‐acting antivirals has failed

By  

HEPATOLOGY, Vol. 62, Iss. 1, 2015-07 ,pp. : 129-134

John Wiley & Sons Inc

Access to resources Recommend Favorite

Changes in serum lipid profiles caused by three regimens of interferon‐free direct‐acting antivirals for patients infected with hepatitis C virus

By  

HEPATOLOGY RESEARCH, Vol. 48, Iss. 3, 2018-02 ,pp. : E203-E212

John Wiley & Sons Inc

Access to resources Recommend Favorite